This study is looking at how telehealth visits can help patients newly diagnosed with high-grade glioma (a fast-growing brain tumor) discuss and document their wishes for end-of-life care. These tumors can quickly affect a person's ability to make decisions, so it's important to have these conversations early. The study will use an "Early START" visit, which is a structured telehealth call (over phone or Zoom) with a healthcare provider. Before the visit, you would receive an educational guide and a copy of an advance directive form. The main goal is to see how many patients complete an advance directive between their diagnosis and their third oncology visit (about 4 months). You might be able to join if you are an adult, speak English, and have a new diagnosis of high-grade glioma within the last four months. The study is planning to enroll 50 participants, but its current status is unclear.

Study design

This is an interventional study, meaning participants will receive a specific intervention (the Early START telehealth visit). It plans to enroll 50 participants.

What's involved

You would participate in an Early START telehealth visit and complete surveys immediately after the visit, 2-4 weeks later, and if applicable, after your death (for caregivers/family).

Compensation

Not stated in the trial record.

Follow-up

Follow-up surveys are conducted immediately after the visit, 2-4 weeks after the visit, and after subject death.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.